Sequence assignments in partially replicate design [Design Issues]

posted by Loky do – Egypt, 2020-07-19 03:33 (922 d 19:01 ago) – Posting: # 21746
Views: 1,995

Dears

In partially replicate 3-way design, FDA recommends using the following example for sequence assignments 1,2,3 --> (TRR, RTR, RRT), if we used different sequence assignments 1,2,3 --> (TRR, RRT, RTR), is this change significant? or is it ok as long as it's considered in statistical analysis?

Thanks in advance

Complete thread:

UA Flag
Activity
 Admin contact
22,477 posts in 4,708 threads, 1,603 registered users;
22 visitors (0 registered, 22 guests [including 5 identified bots]).
Forum time: 21:35 CET (Europe/Vienna)

In these matters the only certainty is
that nothing is certain.    Pliny the Elder

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5